Tom Hewitt

Retired Finance & Operations Senior Leader

Wilmington, Vermont, United States

About

Retired Finance and Operations Senior leader with extensive experience in mergers, acquisitions, integrations and restructuring initiatives

Experience

  • List Services Corporation (Full-time · 3 yrs 6 mos)
    • General Manager
      Jan 2021 - Oct 2022 · 1 yr 10 mos

    • Chief Operating Officer
      Jan 2020 - Jan 2021 · 1 yr 1 mo

    • Chief Financial Officer
      May 2019 - Dec 2019 · 8 mos

  • Pfizer (21 yrs 11 mos)
    • Group Leader, Global Inflammation & Immunology Business Analytics & Insights
      Jun 2017 - Apr 2019 · 1 yr 11 mos

      Provide Business Analytics and Insights to Inflammation and Immunology (I&I) President and I&I global commercial organization to drive business decisions. Lead a global team in developing market and customer insights and commercial recommendations to enable business decisions.

    • Senior Director, Strategy and New Business
      Jan 2016 - May 2017 · 1 yr 5 mos

      Commercial lead for new business assessments and acquisition integration for the Inflammation & Immunology Business Group • Commercial lead in the successful acquisition of Anacor Pharmaceuticals in June 2016 • Integration leader for the Anacor acquisition and designated as site lead at Anacor headquarters in Palo Alto, CA through integration completion • Identify, prioritize and drive external global opportunity evaluation, competitive landscape analysis, business case development and go/no-go decisions • Present commercial strategy and value proposition of new business opportunities to senior executive leadership of Pfizer • Member of Inflammation and Immunology leadership team • Manage and develop direct reports and matrix commercial project teams

    • New Business Lead, Global Marketing and Commercial Development
      May 2013 - Dec 2015 · 2 yrs 8 mos

      Lead and manage the commercial assessment of external business development opportunities(M&A, licensing, co-promotional partnering, etc) for the Global Innovative Pharma Business Unit, with main focus on cardiovascular, metabolic / endocrine and rare diseases.

  • Controller / Director of Reengineering / Director of FP&A and Marketing Analytics at International Masters Publishers, Inc.
    Dec 1991 - May 1997 · 5 yrs 6 mos

    International Masters Publishers, INc. was the U.S. subsidiary of an international direct-marketing publisher based in Sweden. The U.S. subsidiary had annual revenues of approximately $350 million; worldwide revenues were $800 million. Controller - Feb 1997 to June 1997 Responsible for accounting, tax requirements, cash management, collections and financial reporting. Managed staff of twelve. Director of Business Process Reengineering Dec 1995 to Jan 1997 Responsible for review, evaluation and reengineering of business processes throughout the company from a cross-discipline, cross-department/function perspective. Position also involved assisting international group companies in reengineering initiatives. Director of Financial Planning and Marketing Analytics Sept 1993 to Dec 1995 Responsible for all budgeting, forecasting and analysis. Also responsible for review, validation and enhancement of business operational systems, methods and procedures. Restructured Finance organization to also include marketing analysts and reduced overall headcount by 30% while improving quality of analytics. Designed and developed a financial modeling system for use in modeling promotional campaigns and product performance. Provided training to finance teams throughout Europe on financial concepts and methodologies. Managed a staff of six. Assistant Controller – Planning and Analysis Dec 1991 to Sept 1993 -Consolidated marketing plans and provided financial analysis with a team of three direct reports.